1. Home
  2. LEE vs NYXH Comparison

LEE vs NYXH Comparison

Compare LEE & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$8.72

Market Cap

160.1M

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

N/A

Current Price

$3.20

Market Cap

152.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LEE
NYXH
Founded
1890
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Newspapers/Magazines
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.1M
152.8M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
LEE
NYXH
Price
$8.72
$3.20
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
34.3K
45.1K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$543,955,000.00
N/A
Revenue This Year
$5.48
$213.98
Revenue Next Year
N/A
$126.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$2.76
52 Week High
$9.97
$8.64

Technical Indicators

Market Signals
Indicator
LEE
NYXH
Relative Strength Index (RSI) 57.35 45.53
Support Level $8.07 $2.78
Resistance Level $9.40 $3.32
Average True Range (ATR) 0.47 0.19
MACD 0.00 0.05
Stochastic Oscillator 83.50 42.35

Price Performance

Historical Comparison
LEE
NYXH

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: